XT
AGTC

XTX Topco’s Applied Genetic Technologies Corporation AGTC Stock Holding History

XTX Topco’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,606
Closed -$33K – 1042
2021
Q4 		$33K Buy
+17,606
New +$42.2K 0.02% 602

Other funds holding AGTC

CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

XTX Topco's AGTC Position: Q1 2022 in Review

XTX Topco sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2022, closing a stake of 17,606 shares — an estimated $33K sold.

XTX Topco first reported a position in AGTC in Q4 2021 and held it in 1 quarter. The position peaked at $33K in Q4 2021. 53 funds tracked by Wall St. Rank hold AGTC as of Q1 2022.

  • XTX Topco reported no remaining Applied Genetic Technologies Corporation position as of Q1 2022 after selling out during the quarter.
  • XTX Topco sold 17,606 Applied Genetic Technologies Corporation shares in Q1 2022, an estimated $33K.
  • XTX Topco first reported a position in Applied Genetic Technologies Corporation in Q4 2021 and held it in 1 quarter.
  • XTX Topco's Applied Genetic Technologies Corporation position peaked at $33K in Q4 2021.
  • 53 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2022.

Based on XTX Topco's 13F filing for Q1 2022, filed 13 May 2022.